Alzheimer's advocate Tony Gonzales testified before the House Ways and Means Health Subcommittee, advocating for CMS coverage for FDA-approved Alzheimer's treatments. Bipartisan members of the subcommittee expressed their support for the FDA accelerated approval pathway and desire for CMS to change its policy. Gonzales shared his story and emphasized the need for patients to have access to treatments that can give them more time.